Alterity Therapeutics (ATHE) Change in Cash (2016 - 2019)

Alterity Therapeutics has reported Change in Cash for 4 years, with the latest figure at -$1.6 million in Q4 2019.

• For the quarter ending Q4 2019, Change in Cash rose 68.41% year-over-year to -$1.6 million; the trailing twelve-month figure through Dec 2019 stood at -$8.2 million (changed N/A YoY), and the FY2025 full-year result was $13.3 million, up 692.99% from the prior year.
• Change in Cash for Q4 2019 stood at -$1.6 million, up from -$5.1 million in the prior quarter.
• The five-year high for Change in Cash was -$598231.8 in Q4 2016, with the low at -$5.1 million in Q4 2018.
• Average Change in Cash over 4 years is -$2.1 million, with a median of -$1.3 million recorded in 2017.
• Year-over-year, Change in Cash tumbled 444.27% in 2018 and surged 68.41% in 2019.
• Tracing ATHE's Change in Cash over 4 years: stood at -$598231.8 in 2016, then tumbled by 56.04% to -$933486.7 in 2017, then plunged by 444.27% to -$5.1 million in 2018, then surged by 68.41% to -$1.6 million in 2019.
• The last three Change in Cash figures came in at -$1.6 million (Q4 2019), -$5.1 million (Q4 2018), and -$933486.7 (Q4 2017), per Business Quant data.

Peer Comparison